If You Had Invested $10,000 in This Top Warren Buffett Stock 10 Years Ago, Here’s How Much You’d Have Today

Key Points Durable profit gains drove this stock to crush the overall market in the past decade. The valuation multiple has expanded by 246% since ...

Read more

Here’s the Average Net Worth for Americans at 60 — Where Do You Stand?

Key Points Reaching age 60 is a major milestone. You’re likely only two to seven years away from retirement. And you probably think about your ...

Read more

Crypto Market Update: House Bills Aims to Ban Lawmakers From Crypto Prediction Markets

Here’s a quick recap of the crypto landscape for Friday (June 5) as of 12 noon UTC. Get the latest insights on Bitcoin, Ether and ...

Read more

It’s Prime Time for Selling Covered Calls

The correction in AI stocks following Broadcom’s (AVGO) disappointing guidance gave investors a lesson in how quickly momentum can fade. Stocks go up, and stocks ...

Read more

AI Chip Stocks Sold Off This Week. Is AMD a Buying Opportunity or a Falling Knife?

Key Points Semiconductor stocks took a hit this week. The selling began with Broadcom, whose latest quarterly report lacked the wow factor investors had hoped ...

Read more

Koil Energy Rallies 41% in a Year: Should You Buy the Stock?

Koil Energy Solutions, Inc. KLNG shares have climbed 41.2% in the past year compared with the industry’s 26.3% growth. The company has outperformed other industry ...

Read more

Could Nvidia Reach a $10 Trillion Market Cap? I Think So. And It Will Happen Faster Than You Think.

Key Points Nvidia (NASDAQ: NVDA) is the only company ever to reach a $5 trillion market cap. While there are a few milestones between its ...

Read more

Oak Valley Bancorp Gains 26% in a Year: Should You Buy the Stock?

Oak Valley Bancorp OVLY shares have gained 25.9% in the past year compared with the industry’s 18.7% growth. The company has outperformed other industry players, ...

Read more

VTI vs. VOO: Which Vanguard ETF Will Buy More SpaceX Stock After Its IPO?

Key Points S&P Dow Jones Indices just updated its policy on fast-tracking the addition of megacap stocks to the S&P 500. SpaceX won’t be added ...

Read more

AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC

Agenus AGEN centered its investment case on botensilimab plus balstilimab (BOT+BAL), a checkpoint combination being advanced in refractory microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic ...

Read more